Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated:  1/25/2018
Clinical Research Facility
mi
from
Middleburg Heights, OH
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated: 1/25/2018
Clinical Research Facility
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated:  1/25/2018
Clinical Research Facility
mi
from
Lancaster, PA
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated: 1/25/2018
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated:  1/25/2018
Clinical Research Facility
mi
from
Charleston, SC
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated: 1/25/2018
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated:  1/25/2018
Clinical Research Facility
mi
from
Jackson, TN
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated: 1/25/2018
Clinical Research Facility
mi
from
Jackson, TN
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated:  1/25/2018
mi
from
Lille,
Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of MLN9708 for the Treatment of Subjects With ISN / RPS Class III or IV Lupus Nephritis
Status: Enrolling
Updated: 1/25/2018
mi
from
Lille,
Click here to add this to my saved trials
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Immunogenicity and Safety of the Quadrivalent HPV Vaccine Gardasil in Female Systemic Lupus Erythematosus Patients Aged 9-26
Status: Enrolling
Updated:  2/14/2018
University of Chicago
mi
from
Chicago, IL
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Immunogenicity and Safety of the Quadrivalent HPV Vaccine Gardasil in Female Systemic Lupus Erythematosus Patients Aged 9-26
Status: Enrolling
Updated: 2/14/2018
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCLA
mi
from
Los Angeles, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UC Irvine
mi
from
Orange, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UC Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UC Davis
mi
from
Sacramento, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCSD
mi
from
San Diego, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCSD
mi
from
San Diego, CA
Click here to add this to my saved trials
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated:  3/13/2018
UCSF
mi
from
San Francisco, CA
A Complex Contraception Registry
A Complex Contraception Registry - UC Family Planning Collaborative Study
Status: Enrolling
Updated: 3/13/2018
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Gilbert, AZ
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Mesa, AZ
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Phoenix, AZ
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Phoenix, AZ
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
San Leandro, CA
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
San Leandro, CA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Lawrenceville, GA
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Lansing, MI
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Lansing, MI
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Smithtown, NY
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Smithtown, NY
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Charlotte, NC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Greenville, NC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Greenville, NC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Wyomissing, PA
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Wyomissing, PA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Greenville, SC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Greenville, SC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Birmingham, AL
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Tuscaloosa, AL
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Tustin, CA
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Tustin, CA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Orlando, FL
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Flowood, MS
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Brooklyn, NY
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Chapel Hill, NC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Raleigh, NC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Duncansville, PA
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Charleston, SC
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Houston, TX
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Webster, TX
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Webster, TX
Click here to add this to my saved trials
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  3/15/2018
GSK Investigational Site
mi
from
Beckley, WV
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector
An Open-Label Single-Arm Study to Evaluate the Reliability of an Autoinjector That Administers Belimumab Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 3/15/2018
GSK Investigational Site
mi
from
Beckley, WV
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Baltimore, MD
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
La Jolla, CA
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Palm Desert, CA
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
San Leandro, CA
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
San Leandro, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Stockbridge, GA
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Stockbridge, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Shreveport, LA
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Lansing, MI
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Brooklyn, NY
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
Manhasset, NY
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  3/23/2018
Clinical Research Facility
mi
from
New York, NY
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 3/23/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials